| Dr Michele Quinn, MD | |
|
1508 Division St, Suite 205, Oregon City, OR 97045-1582 | |
| (503) 657-1071 | |
| (503) 657-3321 |
| Full Name | Dr Michele Quinn |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 23 Years |
| Location | 1508 Division St, Oregon City, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003073289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD16709 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Healthcare Associates Llc | 8527054014 | 94 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Both physicians and patients overestimate the risk of heart attack or death for possible acute coronary syndrome (ACS) as well as the potential benefit of hospital admission for possible ACS.
Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study by McGill University professor Maziar Divangahi published by Cell Press on April 10 in the journal Immunity reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus.
Understanding of fibromuscular dysplasia (FMD), a rare blood vessel disease, is making the jump from the laboratory to the clinic with new findings about a genetic variant.
Based on an open source platform designed by Krishagni Solutions, OpenSpecimen (formerly known as caTissue Plus) is currently used by a host of highly-respected research institutions across 12 countries where it manages biospecimens from collection to utilisation...
› Verified 9 days ago
| Entity Name | Womens Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346296142 PECOS PAC ID: 8527054014 Enrollment ID: O20040421000823 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Both physicians and patients overestimate the risk of heart attack or death for possible acute coronary syndrome (ACS) as well as the potential benefit of hospital admission for possible ACS.
Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study by McGill University professor Maziar Divangahi published by Cell Press on April 10 in the journal Immunity reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus.
Understanding of fibromuscular dysplasia (FMD), a rare blood vessel disease, is making the jump from the laboratory to the clinic with new findings about a genetic variant.
Based on an open source platform designed by Krishagni Solutions, OpenSpecimen (formerly known as caTissue Plus) is currently used by a host of highly-respected research institutions across 12 countries where it manages biospecimens from collection to utilisation...
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michele Quinn, MD 7650 Sw Beveland Rd, Suite 200, Portland, OR 97223-8692 Ph: (503) 601-3615 | Dr Michele Quinn, MD 1508 Division St, Suite 205, Oregon City, OR 97045-1582 Ph: (503) 657-1071 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Both physicians and patients overestimate the risk of heart attack or death for possible acute coronary syndrome (ACS) as well as the potential benefit of hospital admission for possible ACS.
Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study by McGill University professor Maziar Divangahi published by Cell Press on April 10 in the journal Immunity reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus.
Understanding of fibromuscular dysplasia (FMD), a rare blood vessel disease, is making the jump from the laboratory to the clinic with new findings about a genetic variant.
Based on an open source platform designed by Krishagni Solutions, OpenSpecimen (formerly known as caTissue Plus) is currently used by a host of highly-respected research institutions across 12 countries where it manages biospecimens from collection to utilisation...
› Verified 9 days ago
Dr. Frederick G Schmidt, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1508 Division St, Suite 205, Oregon City, OR 97045 Phone: 503-657-1071 Fax: 503-657-3321 | |
Bertha Moseson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1425 Beavercreek Rd, Oregon City, OR 97045 Phone: 503-655-8471 Fax: 503-655-8595 | |
Mr. Harold Desmond Johnson, MEDICAL DOCTOR Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1508 Division St, Ste 205, Oregon City, OR 97045 Phone: 503-657-1071 Fax: 503-657-3321 | |
Brandi L Vasquez, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1508 Division St, Ste 205, Oregon City, OR 97045 Phone: 503-657-1071 Fax: 503-657-3321 | |
Michael P Nielsen, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1508 Division St, Suite 205, Oregon City, OR 97045 Phone: 503-657-1071 Fax: 503-657-3321 | |
Dr. Ari Menashe Heffron, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1508 Division St, Suite 205, Oregon City, OR 97045 Phone: 503-657-1071 |